Efficacy trials launch for tuberculosis vaccine; The latest health stories from around the world
A large-scale efficacy trial of a promising tuberculosis (TB) vaccine will soon launch with substantial backing from two major philanthropies. The vaccine, dubbed M72, has so far crawled through clinical trials. A placebo-controlled study completed in 2015 found that in adults who had latent infections with the TB-causing mycobacterium, those who received the vaccine had …